摘要
目的:了解我院2008-2010年门诊血脂调节药物使用情况,为临床合理用药提供参考。方法:采用销售数量、金额排序及频度分析的回顾性调查分析方法,对我院2008-2010年门诊血脂调节药物的使用进行统计分析。结果:我院门诊血脂调节类药物销售数量及销售金额逐年上升,2009年和2010年门诊血脂调节药的销售量比2008年分别增长了25%和25.89%。其中羟甲基戊二酰辅酶A(HMG-CoA)还原酶抑制剂销售额最高,其他类药物用药量较小。结论:HMG-CoA还原酶抑制剂在我院门诊血脂调节药物销售中占主导地位。
Objective:To analyze the use of antihyperlipidemics in outpatients of our hospital during 2008-2010 and provide reference for rational drug use in clinic. Methods:The sales amount, consumption sum and DDDs of antihyperlipidemics in our hospital from 2008 to 2010 were analyzed retrospectively. Results:The sales amount and consumption sum of antihyperlipidemics used in outpatient of our hospital increased year by year. The sales amount of antihyperlipidemics increased by 25% in 2009 and 25.89% in 2010 compared with that of in 2008. The consumption sum of HMG-CoA reductase inhibitor ranked the first in antihyperlipidemics. Conclusion:Among the antihyperlipidemics used in outpatients of our hospital, the consumption of HMG-CoA reductase inhibitor took a leading place.
出处
《中国执业药师》
CAS
2012年第2期19-21,共3页
China Licensed Pharmacist